---
title: Cellipont Bioservices vs Omniabio
slug_a: cellipont-bioservices
slug_b: omniabio
site: cdmo
review_signal_gate: closed
canonical_path: /compare/cellipont-bioservices/omniabio
---

# Cellipont Bioservices vs Omniabio

Side-by-side profile data from each company listing on this directory.

## Cellipont Bioservices

- Profile: [/companies/cellipont-bioservices](/companies/cellipont-bioservices)

Cellipont Bioservices — Cellipont Bioservices is a cell therapy CDMO offering end-to-end development, analytical, and cGMP manufacturing services for autologous, allogeneic, CAR-T, and iPSC-derived therapies from preclinical through commercial stages.

Services: 9. Modalities: 1. Indications: 1. Locations: 1. Certifications: 2. The strongest documented coverage currently appears in services (9).

### Services

- Cell-Line Development
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Cell Therapy

### Development capabilities

- Analytical method development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Expression: Mammalian
- Expression: Cell-Free
- Single-Use / Disposable

## Omniabio

- Profile: [/companies/omniabio](/companies/omniabio)

Omniabio — OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.

Services: 8. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Cell-Line Development
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Process Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)